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Abstract
Cryptococcus neoformans is an encapsulated fungus with worldwide distribution and associated
with pigeon excreta. C. neoformans causes pulmonary cryptococcosis in immunocompromised
populations, which results in high mortality. C. neoformans main virulence factor is its
polysaccharide capsule that confers the fungus with the ability to form biofilms. Interkingdom
interactions can have a positive, neutral or negative effect on C. neoformans in relation to its
virulence and/or pathogenicity. C. neoformans survival within polymicrobial and other
challenging communities has been shown to affect the evolution of its virulence factors. For
example, the size of C. neoformans polysaccharide capsule is modulated during interactions with
bacteria and/or immune cells suggesting that understanding the fungus environmental
interactions may help us understand C. neoformans pathogenesis. Here, we used Next
Generation Sequencing (NGS) to identify the microbial populations (e.g. bacterial, fungal and
protist) in pigeon excreta in order to better understand C. neoformans evolution of virulence.
Pigeon excreta samples were collected in Texas and New York, USA. DNA extraction was
conducted using the Zymo Quick-DNA Fecal Microbe Kit. PCR was conducted on the pigeon
excreta samples using four different universal sets of primers to identify 16S, 18S and Internal
Transcribed Spacer (ITS) regions of microorganism’s chromosomes. After amplification, gel
electrophoresis and purification were conducted using 2% agarose gels and PureLink Quick Gel
Extraction Kit. Sample preparation was continued using the Illumina 16S protocol for the MiSeq
system contained steps like PCR cleanups, indexing, and normalizing bioinformatic analysis of
sequencing data was conducting using Qiime 2.0. The sequencing identified C. neoformans in all
the samples collected. Other pathogens identified included: Aspergillus flavus, A. niger, Candida
Kruisii, C. parapsilosis, C. tropicalis, Lactobacillaceae species, Enterbacteriaceae species,
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Acetobacteraceae species, and Aranciocystis muskarensis. Further studies are warranted to
elucidate the results of complex C. neoformans interactions with other microbes in the
environment and the impact of these symbioses in the evolution of virulence and survival
mechanisms developed by this fungus in the human host.
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Chapter 1: Introduction
Cryptococcus neoformans
Throughout time, microorganisms have caused infectious diseases in humans and finding
innovative treatments has been a crucial mission in medicine. In the last quarter of the 20th
century, fungal infections became more common and have been linked with an increase in the
immunocompromised population, primarily HIV+/AIDS patients, but can also be associated to
the development of aggressive surgeries, organ transplantation, and immunosuppressive
therapies (Idnurm, 2005). C. neoformans is a yeast-like, encapsulated fungus that is distributed
worldwide and commonly associated with pigeon excreta.
C. neoformans causes cryptococcosis, which is acquired through inhalation of infectious
C. neoformans basidiospores or desiccated yeast cells. When spores adhere to respiratory tissue,
the pulmonary infection may persist and remain latent for years. However, in the absence of
intact cell-mediated immunity, C. neoformans becomes invasive and progresses to systemic
cryptococcosis. Cryptococci from the lung disseminate to the brain by crossing the blood-brain
barrier (BBB) causing lethal meningoencephalitis even under optimal antifungal therapy
(O'Meara, 2012). Additionally, cryptococcosis can cause pneumonia-like illness and skin lesions.
It has been estimated that there are approximately 220,000 cases of cryptococcal meningitis per
year amounting to nearly 181,000 annual deaths worldwide. C. neoformans accounts for 15% of
AIDS-related mortality (Rajasingham, 2017). The majority of cryptococcal meningitis cases
occur in Sub-Saharan Africa resulting in an estimated 162,500 reported cases each year. The
overall number of deaths due to cryptococcosis have decreased over the years largely in part by
the development of more efficacious treatments against HIV. However, cryptococcosis remains a
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considerable burden in the regions of the world where it is endemic such as sub-Saharan Africa
(Table 1) (Rajasingham, 2017).

Figure 1: Global distribution of cryptococcal infections.

The total number of cryptococcal antigenaemia estimated at 278,000 (95% CI 195 500–340,600)
globally. There are approximately 223,100 incidences of cryptococcal meningitis worldwide
(Rajasingham, 2017).
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Table 1: Burden of cryptococcal; infection by region.

Total Cryptococcal

Burden of

Deaths from

Antigenaemia

Cryptococcal

Cryptococcal

Positive

Meningitis

Meningitis

Sub-Saharan Africa

204,300

162,500

135,900

Asia And Pacific

52,300

43,200

39,700

Caribbean

1,800

1,400

700

Latin America

7,000

5,300

2,400

North America

3,700

3,000

700

North Africa and Middle

3,600

3,300

1,900

Europe

5,200

4,400

1,800

Global

278,000

223,100

181,100

East

The estimated number of infections, burden and deaths caused by cryptococcosis per region
globally (Rajasingham, 2017).
C. neoformans capsule
The most important virulence-associated factors for C. neoformans is its polysaccharide
capsule. The capsule plays a major role as a protective barrier against environmental predators,
environmental stress and host immunity (Zaragoza, 2009). The unencapsulated C. neoformans are
non-pathogenic and cannot cause cryptococcosis in patients (Vecchiarelli, 2000). In the host, the
capsule reduces the immune response by down regulating inflammatory cytokines (Retini, 1998),
3

and by evading macrophage phagocytosis (Cross, 1995). Interestingly, the polysaccharide capsule
is essential for C. neoformans biofilm formation (Martinez, 2005). Contact between C. neoformans
capsule and host cells is believed to play a critical role in its pathogenesis of cryptococcal
meningitis (Charlier, 2005). In a study investigating the capsule role in C. neoformans invasion of
the BBB, it was shown that crossing of the fungal cells through the BBB was early during infection
and the cryptococcal capsule structure changed according to host tissue and not fungal load
(Charlier, 2005). The C. neoformans polysaccharide capsule is composed primarily of
glucuronoxylomannan (GXM) glucuronoxylomannogalactan (GalGXM) and mannoprotein.
GXM is made of O-acetylated α-1,3-linked mannose residues with xylosyl and glucuronyl side
groups (Kozel, 2003), while GalGXM is an α-1,6-linked galactose polymer with mannose, xylose,
and glucuronic acid modifications (Heiss, 2009). The capsule is synthesized inside the cell and
transported across the cell wall through vesicles and attached to the cell wall.
C. neoformans biofilms
An additional characteristic of C. neoformans that allows for an increased virulence is its
ability to form biofilms. Biofilms are a complex network of microbial cells that produce a
polymeric matrix made up of polysaccharides, proteins, and DNA. C. neoformans biofilms has
different stages of development; early, intermediate and maturation stages. In the early stage of
C. neoformans biofilm formation the fungal cells adhere to the surface. During the intermediate
stage, fungal cells are homogenously aggregated in a microcolony at the location where the cells
attached. This stage provides the initial environment needed for nutrient gradients, quorum
sending, and possibly genetic exchange (Martinez, 2005). C. neoformans mature biofilms are
tightly arranged with yeast cells embedded within GXM and other extracellular material. This
arrangement allows for the exchange of nutrient and gas while provided a physical protective
barrier against predators, host immune system and antifungal drugs (Martinez, 2005). Biofilm
environments are interactive and can have cellular communication throughout the systems
4

known as quorum sensing. Quorum sensing forms a means of communication between the cells
that promote collective behavior, which can establish high survival rates and propagation (JabraRizk, 2011). Approximately, 80% of clinical bacterial infections are caused by biofilm
formation. These nosocomial infections are usually found in catheters and other medical
equipment, as well as human surfaces like teeth, heart valves, and lungs (Hoiby, 2010). In this
regard, C. neoformans forms biofilms in ventrculoatrial shunts, which are used to release the
intracranial pressure in patients with cryptococcal meningoenecephalitis (Bakay, 1986). Mature
biofilms can also cause infections that under normal circumstances are treated with ease to
become antibiotic resistant. This process can occur through the increase of mutations that are
induced by environmental stress, as well as, through horizontal transfer of resistance genes
between microorganism within the biofilm. The formation of biofilms by pathogens can increase
antibiotic resistance between 10 and 1,000 times more than planktonic cells or individual nonbiofilm forming organisms (Reffuveille, 2014). C. neoformans biofilms demonstrate
considerable resistance to commonly used antifungal drugs (Martinez, 2006). Biofilms also
cause tolerance against chemical disinfectants and phagocytosis (Hoiby, 2010). Currently, the
only treatment for biofilm- related infections is using higher antibiotic doses than those needed to
treat planktonic cells (Ribeiro, 2016). This treatment method often fails due to infection
persistence.
C. neoformans Interkingdom Interactions
Polymicrobial interactions consist of a combination of bacteria, fungus, parasites and/or
viruses. These polymicrobial interactions can have a positive, neutral or negative effect in
relation to virulence or pathogenicity. In humans, polymicrobial infections can cause a synergetic
relationship, also known as “microbial interference”, where the first organism can create a niche
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and allow the second organism to colonize where it is otherwise not able to (Brogden, 2002).
Phenomena such as horizontal gene transfer and indirect pathogenicity allow for treatment of
these polymicrobial infections to be difficult. Horizontal gene transfer is mediated by dense
biofilms that permit plasmids and other genetic material to be transferred between organisms in
the same community (Jabra-Rizk, 2011). This can allow organisms which were previously
avirulent to become virulent by up taking treatment resistance genes or other virulence
determinants (Molin, 2003). Indirect pathogenicity in a polymicrobial infection allows for one
organism to benefit while the other is unaffected. This action can be particularly harmful to a
patient when the resistant organism protects and enables the antibiotic-sensitive organism to
thrive (Jabra-Rizk, 2011).

Figure 2: Depicts the different types of interaction between fungi and bacteria.
There are nine different potential outcomes when fungi and bacteria interact. The
relationships can be positive, negative, or neutral. Fungal-bacterial interaction can lead to an
increase in proliferation, melanin production and capsule formation which are all positive
outcomes (Blue). These outcomes increase virulence and pathogenicity of the pathogen. However,
some interaction can lead to inhibition of growth, melanin production and capsule formation which
can lead to pathogen susceptibility (Orange). Lastly, fungal-bacterial interaction can be neutral
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meaning that there is no effect that could cause increase in virulence or susceptibility (White)
(Mayer, 2019).
Polymicrobial interaction affects the growth and virulence factor expression of C.
neoformans (Figure 3). Interaction between C. neoformans and Acinetobacter baumannii
displayed a reciprocal inhibition of growth and an induction of C. neoformans capsule
production (Abdulkareem, 2015). Interaction of C. neoformans serotype A and A. baumannii
showed the ability of C. neoformans to create stronger biofilms and have increased survival rate.
These two changes are important because they could explain the ability of the fungus to survive
in harsh and competitive environments (Abdulkareem, 2015). Other bacteria such as
Staphylococcus aureus and Pseudomonas aeruginosa inhibit growth of C. neoformans while C.
neoformans has no effect on their viability. Bacillus subtilis inhibits both capsule formation and
melanin production through chitinase activity (Mayer, 2019). Klebsiella aerogenes interaction
with C. neoformans resulted in brown pigmentation or melanin production by the fungal colonies
(Frases, 2006). C. neoformans interaction with Acanthamoeba castellanii showed that
phospholipids of the amoebae triggered the fungus to have a four-fold increase in capsule
volume (Chrisman, 2011). C. neoformans and A. castellanii interaction demonstrated
phagocytosis of the fungus by the amoeba, amoebae killing, and replication of fungal cells
similar to behavior observed in macrophages (Steenbergen, 2001). Polymicrobial interactions
have become an increasingly significant area of study to understand the complexity of microbial
virulence and pathogenicity.

7

Figure 3: The effects of bacterial interaction on C. neoformans.
The observed effect (positive, negative and neutral) of P. aeruginosa, B safensis, A.
baumanii, S. aureus, K. aerogenes and others. The orange arrows represent interactions causing
negative effects on C. neoformans viability or virulence factor expression. While blue arrows
represent positive effects on C. neoformans viability or virulence factor expression (Mayer,
2019).
Next Generation Sequencing
Over the past two decades, sequencing technology has improved significantly not only in
quality, but in speed and affordability. This triggered an exponential amount of opportunities for
8

further study using this innovative technology (von Bubnoff 2008). Next Generation Sequencing
(NGS) uses DNA polymerase to catalyze the addition of fluorescently labeled
deoxyribonucleotide triphosphates (dNTPs) into the DNA template strand. Through sequential
cycles of DNA synthesis, the fluorescent dNTPs are identified by fluorophore excitation. Unlike
other sequencing techniques prior to the introduction of NGS, NGS completes this process across
millions of fragments in a parallel format. There are several different companies that now offer
NGS including the Illumina MiSeq system that works with amplification of DNA fragments by
isothermic bridge PCR (Reuter, 2016). Bridge PCR simultaneously amplifies single DNA
molecules and contently links amplicons to a solid substrate to a controlled physical location.
Once linked, the sample forms randomly arrayed clusters. The clusters are read repeatedly with
multiple cycles of single-base extension with the fluorescently labeled, reversible chain
terminators (Salipante, 2014).
Metagenomics the study of genetic material obtained from environmental samples. This
type of work investigates the microorganisms that compose environmental micobiomes. In
metagenomics, NGS research, there are two main types of sequencing techniques: Amplicon
sequencing and Whole-genome shotgun sequencing. Amplicon sequencing uses conserved
regions of genomes to identify the microorganisms in samples. These regions are rRNA genes
that are used often as universal constant region for the study of phylogenetic relationships or
characterization. The 16S ribosomal RNA gene is widely used as a constant region for bacteria.
The 16S rRNA gene has been widely used for its presence in almost all bacteria, length which
allows it to be used for informatics purposes, and because the gene has changed little over time
(Janda, 2007). The 18S ribosomal RNA gene is used as a universal constant region for
Eukaryotes, specifically protozoa. The 18S ribosomal gene has nine highly variable regions V1
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to V9. However, the most effective for identification of microbial communities have been
confirmed to be V4 and V9 regions as they are the ones most specific to eukaryotes and best
suited for biodiversity studies (Hadziavdic, 2014). Internal Transcribed Spacer (ITS) ribosomal
RNA gene is a universal constant region for fungi. The ITS region was proved to have highest
probability of successful identification for the broadest range of fungi as compared to other
identifying regions (Schoch, 2011).

Figure 4: Illumina Next Generation Sequencing Overview.
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The figure depicts the four different steps in the Illumina MiSeq NGS system. Library
preparation involved addition of adapters and several steps on PCR (A). After library
preparation, fragments are amplified into clonal cluster by bridge amplification (B). Sequencing
is then conducted by reading fluorescently labeled nucleotides (C). Lastly, sequences are aligned
to reference sequences with bioinformatics software (Illumina, 2020).
NGS requires a total of four steps: library preparation, cluster generation, sequencing, and
data analysis. Library preparation of the DNA or cDNA sample is the process of preparing the
samples with random fragmentation. The library is then ligated to complement the 5’ and 3’
adapters. Adapter-ligated fragments are amplified through polymerase chain reaction (PCR).
Cluster generation begins with capturing fragments onto a lawn of surface-bound oligos
complementary to the library adapters. Once attached the fragment is amplified through bridge
PCR, creating clusters. Following cluster formation, the incorporated fluorescently labeled
DNTPS are read using a reversible terminator-based method that can detect each single dNTP.
Lastly, sequences are aligned to reference genomes for identification of sequence. This process
uses bioinformatics tools like Qiime 2 a Next Generation microbiome bioinformatics platform that
is extensible, free and open sourced. Qiime 2 takes sequences and aligned them to reference
genomes of microorganisms. This platform can be used to identify sequences but also organize
and display data (Bolyen,
Significance
Despite the introduction of antiretroviral therapies that have led to the decrease of
HIV+/AIDS patients, large numbers of C. neoformans infections still occur each year. With C.
neoformans being the second largest cause of death in the immunocompromised AIDS
population, only coming marginally second to tuberculosis, the urgency to understand the impact
of interkingdom interactions, with the ability to impact pathogenicity and virulence, is
11

heightened (Rajasingham, 2017). C. neoformans and M. tuberculosis co-infections have been
medically described in every continent (Chen, 2016 and Sawai, 2018 and Aoi, 2015 and
Martinez-Longoria, 2014). When C. neoformans interacts with other organisms, the
polysaccharide capsule often increases in size, possibly increasing its virulence as well. The
capsule is also a key element in the formation of C. neoformans biofilms. Mature biofilms can
not only evade the host immune system, but also create niches that prevent the penetration of
antifungals. C. neoformans biofilm-derived cells were recently shown to modify their capsular
surface and inhibit phagocytosis by macrophages (). Polymicrobial interactions have become
increasingly more important to study. Recent data have investigated the impact of bacterial
interaction on C. neoformans, but considerable gaps of knowledge in fungal and protist
interactions with C. neoformans remain. One study, however, showed that C. neoformans can
use A. castellanii as a replicating niche similarly to C. neoformans interaction with macrophages
(Steenbergen, 2001). In addition, previous studies have isolated and identified C. neoformans
from pigeon excreta all over the world using a variety of techniques such as PCR amplification
and culturing techniques, although the microbial population living with C. neoformans in its
natural niche has not been extensively described using NGS (Mohammad, 2003), (Kielstein,
2000). However, pigeon excreta samples were sequenced using the Illumina MiSeq system for
the investigation of viral metagenomics. The study explored the presence of viral species
associated with pigeon excreta due to the importance bird being the most common transmitter of
zoonotic diseases. The study discovered a large variety of viruses that colonized pigeon excreta
like viruses that infect plants, insects, and mammals. Some of the viruses identified belong to the
following families: Germinividae, Nanoviridae, Caulimoviridae, Iflavirus, Tetnovirus, Chronic
bee paralysis virus, Circoviridae, Parvovirinae subfamily, Picornavirus, Rotavirus, Adenovirus,
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Astrovirus, and Calicivirus (Phan, 2013). This study showed the potential for further
metagenomic studies in the pigeon excreta microbiome. Identification of inter-kingdom
interactions between C. neoformans and other microorganisms are important due to their
potential to influence C. neoformans virulence and pathogenesis in the mammalian host.

The objective of this project is to identify the interkingdom interactions of C. neoformans in
pigeon excreta, which is the fugus environmental niche.

Aim 1: To collect and extract DNA from pigeon excreta samples isolated from the
southwest and northeast of the United States.

Aim 2: To identify the interkingdom interactions of C. neoformans in pigeon excreta using
NGS.
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Chapter 2: Methods
Sample Collection
Pigeon excreta samples were collected in El Paso, Texas and New York City. Samples
were collected from shaded areas that were not exposed to direct sunlight given previous
descriptions of C. neoformans environmental niche (Ruiz-Acevedo, 1981). After collection, the
samples were placed individually in petri dishes and labeled with coordinates, sample numbers,
physical location, and any distinguishing characteristics such as freshness or quality of sample.
The samples were then stored at -80˚C until needed for further use. There were 100 samples that
were collected in El Paso, Texas (Figure 4A). There were 22 samples collected in New York City
(Figure 4B).

Figure 5: Depicts the geographical location of the samples collected in El Paso, TX (A) and New
York City (B).
Coordinates for each sample were geographically traced using Google Earth.
DNA Extraction and Purification
DNA extraction was conducted using the Qiagen DNeasy PowerSoil Kit and Zymo QuickDNA Fecal/Soil Microbe Kit. Each sample was weighed, and 0.25 g were homogenized and lysed
in buffer solution containing small beads. The sample is vortexed to ensure homogenization and
14

lysis. This step helped distribute sample particles, dissolve humic acids and protect the nucleic
acids from degradation. The samples were then centrifuged at 10,000 x g for45 sec. The
supernatant was transferred to a clean tube and the second solution was added and incubated at
4℃ for 5 min. The Inhibitor Removal Technology (IRT) was used to begin the process of removing
both non-DNA organic and inorganic material from samples to achieve desired DNA purity. The
sample was centrifuged at 10,000 x g for 30 seconds to a minute. The supernatant was collected
while carefully avoiding the pellet, which contained non-DNA organic and inorganic debris. Next,
solution 3 was added and incubated at 4℃ for 5 min. IRT and second reagent also removed any
additional non-DNA organic and inorganic debris from the sample. Again, the sample was
centrifuged at 10,000 x g for 30 seconds to a minute and the supernatant was transferred into a
new collection tube. A high concentration salt solution t5grfv cwas mixed well and added to the
samples. Solution 4 is a high concentration salt solution that adjusts the DNA solution salt
concentrations to allow DNA binding. The sample was centrifuged at 10,000 x g for a minute. The
sample was then loaded onto a spin column and centrifuged at 10,000 x g for a minute. The flow
through was discarded and the step was repeated twice. Next, ethanol was added to the sample and
centrifuged at 10,000 x g for 30 seconds to a minute. This cleaned the DNA bound to the spin
column. Lastly, sterile elution buffer was added to the sample and centrifuged at 10,000 x g for 30
seconds. Elution buffer released the DNA bound to the spin column. The samples were then stored
in -20℃ until further use.
Polymerase Chain Reaction and DNA Band Purification
The DNA extracted from the pigeon excreta samples were amplified with four different
sets of primers to identify 16S regions, 18S regions, and ITS regions of microorganism
chromosomes. These regions are rRNA genes that are often used as universal constant region for
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the study of phylogenetic relationships or characterization. The 16S ribosomal RNA gene is
widely used as a constant region for bacteria. The 18S ribosomal RNA gene is used as a
universal constant region for Eukaryotes, specifically protozoa. ITS ribosomal RNA gene is a
universal constant region for fungi. The 16S primers were selected from the 16S Metagenomic
Sequencing Library Preparation protocol. The fungal primers were taken from the Illumina
Fungal Metagenomics Sequencing Demonstrated Protocol. Moreover, the protist primers were
selected from previously published study (Maritz, 2017)
The 16S Metagenomic Sequencing Library Preparation protocol provided by Illumina
was used for the preparation of the samples in order to perform Next Generation Sequencing
(NGS). After selection of the universal kingdom primers, an overhang was added to the primer to
allow for sequencing. The overhang is as follows:
Forward overhang: 5’ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG‐ [locus‐
specific sequence]
Reverse overhang: 5’ GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG‐ [locus‐
specific sequence]
The overhang adapter sequences must be added to locus‐specific primers for the region to be
targeted. This method is used to target other regions on the genome for either 16S with other sets
of primer pairs, or non‐16S regions throughout the genome.
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Table 2: Primers used for PCR.
Primer Name
16S Amplicon Forward Primer
16S Amplicon Reverse Primer
ITS Amplicon Forward Primer
ITS Amplicon Reverse Primer
18S V4 (TAReuk454FWD1) Amplicon
Forward Primer
18S V4 (TAReukREV3) Amplicon
Reverse Primer
18S V9 (1391f) Amplicon Forward
Primer
18S V9 (EukBr) Amplicon Forward
Primer

Primer Sequence
5’TCGTCGGCAGCGTCAGATGTGTATAAGA
GACAGCCTACGGGNGGCWGCAG
5’GTCTCGTGGGCTCGGAGATGTGTATAAG
AGACAGGACTACHVGGGTATCTAATCC
5’CTTGGTCATTTAGAGGAAGTAA
5’GCTGCGTTCTTCATCGATGC
5′ CCAGCASCYGCGGTAATTCC
5′ACTTTCGTTCTTGATYRA
5′GTAC ACACCGCCCGTC
5’ TGAT CCTTCTGCAGGTTCACCTAC

The table lists the four different primer sets for 16S, ITS and 18S amplification.

Table 3: PCR reaction set up.
Item

Quantity

Microbial DNA (5 ng/µl)

2.5 µl

Amplicon Forward Primer (1 µM)

5 µl

Amplicon Reverse Primer (1 µM)

5 µl

2xKAPA HiFi HotStart ReadyMix

12.5 µl
Total = 25 µl

The table shows the consumable, concentrations and quantity need for PCR reaction.
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Table 4: PCR conditions for primer sets.

PCR conditions for 16S and ITS reactions (A). PCR conditions for 18S V4 and V9 (B).

Gel electrophoresis was conducted on the samples to separate the multiple DNA bands that
were present. Tris-Acetate-EDTA (TAE) 50X buffer (Fisher Scientific) and then diluted to 1X
TAE. The agarose gels were prepared to be 2% agarose per recommendation of the Invitrogen
PureLink Quick Gel Extraction Kit purification kit. Ethidium bromide (EtBr) at the concentration
of 0.5 µg/ml was used to bind to DNA to be made visible under ultraviolet (UV) light. Gel wells
were loaded with 25 µl of sample and 5µl of Thermo Scientific TriTrack DNA Loading Dye.
Sample to loading dye ratio was 1µl of loading dye for every 5µl of sample. Gels were run at 80V
for about an hour. After the gel run, the gel was viewed under the UV light. DNA bands were cut
and extracted according to expected band size for primers; reference Table 4. Extracted gel was
then purified.
Purification of samples was conducted using the Invitrogen PureLink Quick Gel
Extraction Kit. The extracted gel slice containing the DNA fragment was weighed using a scale
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sensitive to 0.001g. The gel solubilization buffer (L3) was then added at a 3 to 1 ratio with gel
weight. 1.2ml of buffer was added for every 400 mg of gel fragment. The tube containing the gel
slice and buffer was incubated at 50°C in a water bath for 10 min. The tube was inverted every 3
min to ensure gel dissolution. After the incubation and gel appeared to be dissolved, the sample
was incubated for an additional 5 min. The sample was then added to the Quick Gel Extraction
Column inside wash column and centrifuged at >12,000 x g for 1 min. The flow-through was
discarded and 500 µl of Wash Buffer (W1) that contained ethanol was added. The sample was then
centrifuged at12,000 x g for 1 min. Flow-through was then discarded and centrifuged an additional
time at maximum speed for 2 min. After, the column was placed in a recovery tube and 50 µl of
elution buffer was added the column. The sample was then incubated at room temperature for 1
min and centrifuged at > 12,000 x g for 1 min. Once the process of purification was complete the
purified DNA was stored at -20°C. PCR was conducted confirm the fragment size.

Table 5: Expected band size.

The table shows expected band sizes for each individual primer; 16S Amplicon Primer,
18S Amplicon Primer, 18S V4 Amplicon Primer and 18S V9 Amplicon Primer.
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Then, PCR was conducted on the purified DNA the Agilent 4200 TapeStation system
was used to determine the size, concentration and integrity of pigeon excreta DNA samples prior
to the continuation of NGS. This system is an automated electrophoresis tool used for sample
quality control. All pigeon excreta DNA samples that were amplified were analyzed through
Tapestation before the continuation of the 16S Metagenomic Sequencing Library Preparation
protocol for NGS.
Next Generation Sequencing
The process of NGS was started with the initial library set up by amplifying the sample
DNA by PCR. After the initial amplicon., PCR clean-up was conducted. This step allowed for
additional purification of the samples. The AMPure XP beads remove any free primers and primer
dimer species. The process of PCR clean-up began by centrifuging the samples at 1,000 x g at
20°C for 1 minute to collect condensation around the tube. PCR samples were then transferred to
the PCR plate. AMPure XP beads were vortexed for 30 sec and 20 µl of beads were added to each
well. The PCR plate was then sealed and then shook at 1800 rpm for 2 min. After mixing the
sample and the beads, the plate was incubated at room temperature for 5 min. The plate was then
put on a magnetic stand for 2 min until the supernatant was cleared. While the plate was on the
magnetic stand, the supernatant was removed and discarded. The beads were then washed with
200 µl of freshly prepared 80% ethanol and then incubated for 30 sec. After incubation, the
supernatant was removed and discarded. An additional ethanol wash was performed in the same
manner as mentioned, previously. On the magnetic plate, the beads were allowed to dry for 10
min. After the beads were dry, the plate was removed from the magnetic plate and 52.5 µl of 10
mM Tris pH 8.5 was added to each well of the PCR plate. The beads and Tris were mixed gently
by pipetting up and down 10 times to completely resuspend beads in solution. The plate was then
incubated at room temperature for 2 min. An additional incubation was conducted on the magnetic
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plate for 2 min until the supernatant was clear. Lastly, 50 µl of the supernatant was transferred to
a new microtiter plate.
After PCR clean-up, the samples had dual indices and Illumina sequencing adapters were
added using the Nextera XT Index Kit. Taking the microtiter plate that contained the samples after
PCR clean-up, 5 µl were transferred to a different, clean microtiter plate. The Index 1 and 2 primers
were arranged as shown in Figure 5. The PCR reaction was set by adding the following to
microtiter plate containing the sample DNA; 5 µl Nextera XT Index Primer 1 (N7xx), 5 µl Nextera
XT Index Primer 2 (S5xx), 25 µl 2x KAPA HiFi HotStart ReadyMix and 10 µl of PCR grade
water. Once all the reagents were added to the plate, the solution was gently mixed. Next, the plate
was sealed and centrifuged at 1,000 x g at 20°C for 1 min. The PCR to add the Index to the samples
was conducted as shown in Figure 6.

Table 6: TruSeq Index Plate Fixture.

The arrangement of TruSeq Index Plate. (A) Index 2 Primer (white caps). (B) Index 1
primers (orange caps). (C) microtiter.
21

Table 7: Index PCR set up.

Table 8: Index PCR conditions.

After the dual indices and Illumina sequencing adapters were added to the samples, a
second PCR clean-up using AMPure XP beads was performed for a final clean-up of the final
library before quantification. The Index PCR plate was centrifuged at 280 x g at 20°C for 1
minute to collect condensation on the sides of well. Then, AMPure XP beards were vortexed and
56 µl of beads were added to each well of the Index PCR plate. The solution was then mixed up
and down 10 times. The plate was incubated at room temperature without shaking for 5 min. The
Index PCR plate was then placed on a magnetic stand and incubated at room temperature for 2
min until the supernatant was clear. The supernatant was then removed and discarded. The beads
were washed using 200 µl of freshly made 80% ethanol and incubated on the magnetic plate for
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30 seconds. After incubation, the supernatant was removed and discarded. An additional ethanol
wash was conducted following the same procedure previously mentioned. On the magnetic plate,
the beads were allowed to dry for 10 min. After drying, the plate was removed from the magnetic
plate and 27.5 µl of 10mM Tris pH 8.5 was added and mixed gently 10 times in every well of the
plate. Once the beads were resuspended in the Tris buffer, the plate was incubated at room
temperature for 2 min. The plate was placed on the magnetic plate and incubated at room
temperature for an additional 2 min until the supernatant was clear. Lastly, 25 µl of the
supernatant was transferred into a new microtiter PCR plate.
After the last PCR clean-up validation of the library is conducted. The library was
validated using Bioanalyzer DNA 1000 chip. The process was started by running 1 µl of a 1:50
dilution of the final library on the Bioanalyzer DNA 1000 chip. The expected band size was
compared to the band size measured by the Bioanalyzer trace. The final library for the 16S and
ITS amplicon primers were approximately 630 bp and between 225 and 775 bp.
The quantification of the library was conducted by fluorometrically methods that used
dsDNA binding dyes. First, the concentration of DNA in the samples was calculated in mM
based on the size of the DNA amplicons determined from the validation of the library with the
Agilent Technologies 2100 Bioanalyzer trace. The formula in Figure 6 was used to calculate the
concentration of the libraries. The library was diluted with the 10 mM Tris pH 8.5 to 4 mM.
then, 5 µl of the diluted DNA from each library were aliquoted and mixed for pooling libraries
with unique indices. The samples were required to meet >100,000 reads per sample to
sufficiently survey libraries.
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Figure 6: Mathematical formula to determine the concentration in nM based on the size of DNA
amplicons, as determined by and Agilent Technologies 2100 Bioanalyzer trace.

In order to prepare the libraries for cluster generation, the pooled libraries were denatured
with NaOH, diluted with hybridization buffer, and then heated before MiSeq sequencing. To
dilute pooled libraries, 5 µl of 4 nM of pooled libraries and 5 µl 0.2 N NaOH were combined in a
microcentrifuge tube. The mixture was vortexed briefly and then centrifuged at 280 x g at 20°C
for 1 minute, then incubated at room temperature for 5 min, to denature DNA into single strands.
In the tube containing the denatured DNA, 990 µl of pre-chilled HT1 was added. This resulted in
20 pm denatured library in 1 mM NaOH. The tube was then placed on ice. Additional dilution
was needed to obtain final concentration. To achieve the 10 pM concentration of denatured
libraries, 300 µl of 20 pM denatured libraries was mixed with 300 µl pre-chilled HT1. The
solution was inverted several times and then pulse centrifuged. The solution was then placed on
ice. PhiX was used as an internal control and was processed parallel with our samples. The
combination of the 570 µl of amplicon library and 30 µl of PhiX control was conducted in a
microcentrifuge tube. The tube was set on ice until the heat denatured process began
immediately before loading the samples into the MiSeq v3 reagent cartridge. Heat denature was
performed by incubating the combined library and PhiX control tube at 96°C for 2 min. After
incubation, the tube was inverted twice to mix, and was incubated for 5 min in the ice bath.
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Finally, the libraries were ready to be loaded into MiSeq v3 reagent cartridge and run through the
MiSeq system.
Bioinformatics and Data Analysis
The MiSeq system provided an on-instrument secondary analysis using the MiSeq
Reporter software (MSR). This analysis provided a Metagenomics workflow that output
classification of reads at several taxonomic levels: kingdom, phylum, class, order, family, genus,
and species. The software also analyzed clustering. However, bioinformatic analysis continued
with the use of Qiime2. Qiime2 is a next generation microbiome bioinformatics platform. It is
extensible, free, and open source. Qiime2 was used to compare sample libraries to known sequence
libraries of bacteria, fungi, and protists. From there, the workflow was classified according to the
taxonomic levels, kingdom, phylum, class, order, family, genus, and species for each sample.
Qiime2 was also used to determine the quality of the samples and analyze microbial differences
between location. Most importantly, the bioinformatics tool was used to identify the presence of
C. neoformans in pigeon excreta and identify the microorganisms associated with it.
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Chapter 3: Results
Nanodrop
Nanodrop allows for quantification and sample purity analysis.
Table 9: Nanodrop results.
Sample
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Mass Units
(ng/ul)
1.4
1.82
1.2
1.04
2.05
1.62
1.79
1.86
1.46
1.81
1.47
1.46
1.72
1.82
1.53
1.37
1.86
1.83
1.31
2.01
1.82
1.92
1.84
1.81

The Beer‐Lambert Law A = ɛcl (A=absorbance, ԑ=extinction coefficient, c=concentration
and l=path length) draw a direct correlation between absorbance and concentration. This
correlation allows for the determination of pity and concentration of nucleic acids in a sample.
Nucleic acids have a peak absorbance of UV light at 260nm. The amount of UV light absorbed
can be used to determine the concentration of DNA. Protein absorbs UV light at 280nm ratios
between DNA and contaminants can be used to determine the purity. The ration 260/280 is used
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to determine the amount of protein contamination. A sample with limited contamination would
fall under the range of 2.1 and 1.8. As shown in Table 9, most of the samples contained minimal
protein contamination. However, samples 1, 3, 4, 6, 7, 9, 11, 12, 16, 15, and 19 had more protein
contamination.
TapeStation
The Agilent 4200 TapeStation system results determined the size of bands, concentration of
DNA and integrity of samples.

Figure 7: TapeStation graphs for 16S, ITS, and 18S PCR.
TapeStation results for bacterial PCR (A) had an expect band size of approximately 550
bp. The graph shows a singular peak at 541 bp. Tapestation graph for fungal PCR (B) had an
expected band size of approximately 145 to 695 bp. The graph shows a peak at 375 bp.
Tapestation graph for Protist V9 (C) had an expected band size of approximately 96 to 134 bp.
The graph shows one peak at 219 bp. Tapestation graph for Protist V4 (D) had an expected band
size of approximately 270 to 387 bp. The graph shows one peak at 491 bp.
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Next Generation Sequencing
NGS is a parallel sequencing tool that has high throughput, scalability, and speed. This tool
can be used to look at environment microbiomes.

Figure 8: Identification of Eukaryotic microorganisms with the ITS Primer.
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We identified the presence of C. neoformans and other fungal microorganisms in samples
collected in the southwest and northeast of the United States. More than 40 unique taxonomic
orders were identified (A). Several pathogenic fungal species such as C. tropicalis, C. parapsilosis,
C. kruisii, A. clavatus, and A. flavus were identified in the samples.

Figure 9: Identification of Eukaryotic microorganisms with the 16S Primer.
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We identified the presence of 6 unique taxonomic orders (A). The 16S NGS was only able
to identify microorganisms in the family taxonomic specificity. There was identification of 8
unique families. The Bacteroidales order is composed of 10 families of environmental bacteria.
This order includes Bacteroides, Lactobacillus and Prevotella which are commonly found in the
human gut microbiota. Additionally, the family Clostridiaceae was identified which contains a
variety of pathogenic species like Clostridium difficile, C. tetani and C. botulinum. Lastly, the
family Enterobacteriaceae was also identified. This family contains pathogenic species such
Escherichia coli and K. pneumoniae.
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Figure 10: Identification of Eukaryotic microorganisms with the 18S V4 Primer.
We identified the presence of more than 20 unique taxonomic orders. The 18S V4
metagenomics identified a variety of organisms, but mostly consisted of algae in the phylum
Ochrophyta.
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Figure 11: Identification of Eukaryotic microorganisms with the 18S V9 Primer.
We identified the presence of more than 8 unique taxonomic orders. The 18S V9
metagenomics identified a variety of organisms and consisted mostly of organisms in the Metazoa
family. The Metazoa family is a group of unicellular aquatic protist.
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Chapter 4: Discussion
The pigeon excreta samples collected had DNA successfully extracted and amplified for
sequencing. The preliminary results obtained from the initial PCR confirmed that DNA was
present and amplified for all four-primer set. However, the purity and concentration of the
samples was low. Furthermore, the Tapestation results confirmed that DNA was amplified at low
amounts and was not ready for NGS. The initial PCR required trouble shooting due to the use of
these universal primers that made it difficult to amplify clean and isolate bands. The additional
step of running the samples through gel electrophoresis and gel band purification provided the
concentration and purity needed for NGS. The difficulty can be attributed to the universal rRNA
primers, but it was increasingly more difficult because some of the samples appeared to have
multiple organisms isolated. This was concluded because there appeared to be multiple bands per
PCR reaction that would still fit in the range of the primer set. Three of the four primer sets have
large ranges of expected band sized due to the nature of microorganisms that can be identified.
The fungal and protozoa primers were used for Eukaryotes which can range in complexity and
diversity. After the second purification and amplification, the samples were able to be sequenced
using NGS.
The identification of the microorganism that colonize pigeon excreta is a significant
discovery as there is a gap in the literature. The current literature individually describes the fungi
and viruses that reside in pigeon excreta but does not describe bacteria or protist. The
investigation into the viruses colonizing pigeon excreta showed the importance to study the
microbial populations potentially carried by pigeons (Phan, 2013). In previous fungal sequencing
performed, organisms such as C. neoformans, Candida albidus, Cryptococcus kuetzingii,
Cryptococcus adeliensis, Filobasidium uniguttulatum and Rhodotorula kratochvilovae were
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isolated from pigeon excreta samples (Wu, 2012). In our study, C. albidus, C. kuetzingii, C.
adeliensis, F. uniguttulatum species were not identified in our study. C. neoformans was
identified in the samples and accounted for 0.03% of the microorganisms in all of the samples.
There was the identification of other Candida species including three pathogenic strains: C.
tropicalis, C. parapsilosis, and C. kruisii. In addition, we identified other fungal pathogenic
species such as A. clavatus, and A. flavus. Our approach in looking at multi-kingdom sequencing
allowed for the identification of relevant interaction between C. neoformans and other
organisms. The 16S metagenomics identified several different families that contain pathogens
and relevant microorganisms. The family Clostridiaceae contains a variety of pathogenic species
including Clostridium difficile, C. tetani and C. botulinum. These pathogens are ubiquitous to the
environment and further work should investigate the effect of polymicrobial interaction with C.
neoformans. In addition, the family Enterobacteriaceae was identified. This family contains
pathogenic species such as E. coli and K. pneumoniae. The identification of K. pneumoniae is
interesting as previous studies have shown that interaction between K. pneumoniae and C.
neoformans had an impact on C. neoformans melanization. Melanin is a pigment that protects the
fungus against environmental stress. Due to lower number of reads, the specificity of the 16S
metagenomics did not identify microorganisms into the species level. Lastly, the metagenomics
for the 18s V4 and V9 samples showed a large diversity in protist that colonized pigeon excreta.
The V4 and V9 primers were the least specific to the taxonomic kingdom targeted. The samples
consisted mostly of single celled protists and did not contain DNA from any pathogenic species.
The samples heavily contained DNA from the kingdom Animalia. The identification of DNA
from organism not in the targeted kingdoms can be attributed to the sample collection. All
sampled were collected from areas where animals interacted with pigeons. The 18S region is
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expensive to account for the diversity of the Protista kingdom and amplified DNA from other
eukaryotic cells including organisms from the kingdom Animalia.
Future work will include a second round of 16S metagenomic sequencing to improve the
specificity of the microorganisms present in the samples. The additional round of sequencing
will improve results by identifying species. The Interkingdom interactions have been shown to
upregulate virulence factors and microbial viability of the organisms involved. This will allow a
better approach to investigate and understand the novel mechanisms that affect pathogenicity and
viability. The identification of fungal, bacterial and Protista microorganisms in pigeon excreta
open the possibilities for investigation interkingdom interaction with C. neoformans. Future
work will include the investigation of impact on C. neoformans virulence factors after interaction
with the organisms identified in this study. In addition, in vivo work to see the impact of C.
neoformans pathogenicity after polymicrobial interaction are necessary. As resistance and
persistence become increasingly more common, further investigation is needed to fully
understand how interkingdom interactions affect the virulence of pathogens.
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